Deep learning [18F]-FDG-PET/CT‑based algorithm for tumor burden estimation in metastatic melanoma patients under immunotherapy

PARS shows potential for treatment decision support with moderate accuracy in lesion detection and lesion volume estimation, but demonstrates significant variability in TB estimation, highlighting the need for further model refinements before clinical adoption.

Authors

Institutions

Publication Details

Journal
Clinical and Translational Radiation Oncology
Published
2025-10-28
DOI
https://doi.org/10.1016/j.ctro.2025.101063
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Deep learning [18F]-FDG-PET/CT‑based algorithm for tumor burden estimation in metastatic melanoma patients under immunotherapy

Stephanie Tanadini‐Lang, Matthias Gückenberger, Daniel Abler, Adrien Depeursinge et al.
Clinical and Translational Radiation Oncology
Cancer Immunotherapy and Biomarkers
article

Deep learning [18F]-FDG-PET/CT‑based algorithm for tumor burden estimation in metastatic melanoma patients under immunotherapy

Stephanie Tanadini‐Lang, Matthias Gückenberger, Daniel Abler, Adrien Depeursinge, Sebastian M. Christ, Lorenzo Lo Faro, Simon Burgermeister, Panagiotis Balermpas, Ciro Franzese, Maiwand Ahmadsei, Michel A. Cuendet, Marta Scorsetti, Hubert S. Gabryś, Maksym Fristak
article en

Abstract

PARS shows potential for treatment decision support with moderate accuracy in lesion detection and lesion volume estimation, but demonstrates significant variability in TB estimation, highlighting the need for further model refinements before clinical adoption.

Clinical and Translational Radiation OncologyVol. 56
SIB Swiss Institute of Bioinformatics (CH), Humanitas University (IT), HES-SO University of Applied Sciences and Arts Western Switzerland (CH), Cornell University (US), University Hospital of Zurich (CH), University Hospital of Geneva (CH), IRCCS Humanitas Research Hospital (IT), Geneva College (US), University of Lausanne (CH)
Openalex Percentile: Top 58%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.